ABT-126
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for ABT-126, covering 2010-11-02 to 2021-07-07. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia [Phase 2]